Kerrisdale Advisers, LLC Charles River Laboratories International, Inc. Transaction History

Kerrisdale Advisers, LLC

$264 Million
Q3 2024

A detailed history of Kerrisdale Advisers, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Kerrisdale Advisers, LLC holds 6,505 shares of CRL stock, worth $1.21 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

6,505

Previous 9,780 33.49%

Holding current value

$1.21 Million

Previous $2.02 Million 36.58%

% of portfolio

0.49%

Previous 0.71%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $615,569 - $803,324	-3,275 Reduced 33.49%	6,505 $1.28 Million
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $252,827 - $329,194	-1,225 Reduced 11.13%	9,780 $2.02 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $2.87 Million - $3.86 Million	-14,118 Reduced 56.2%	11,005 $2.98 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $596,714 - $866,272	3,627 Added 16.87%	25,123 $5.94 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $3.3 Million - $3.69 Million	16,952 Added 373.06%	21,496 $4.21 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $834,778 - $955,376	4,544 New	4,544 $955,000
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $1.33 Million - $1.98 Million	-6,536 Reduced 46.73%	7,450 $1.59 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $15.4 Million - $21.8 Million	-60,281 Reduced 81.17%	13,986 $3.97 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $14 Million - $17.8 Million	39,752 Added 115.17%	74,267 $28 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $8.92 Million - $11 Million	-23,939 Reduced 40.95%	34,515 $14.2 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $19 Million - $24 Million	-64,691 Reduced 52.53%	58,454 $21.6 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $14.1 Million - $16.9 Million	-56,503 Reduced 31.45%	123,145 $35.7 Million
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $9.81 Million - $11.2 Million	-44,189 Reduced 19.74%	179,648 $44.9 Million
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $5.05 Million - $6.51 Million	-28,754 Reduced 11.38%	223,837 $50.7 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $391,577 - $625,127	3,295 Added 1.32%	252,591 $44 Million
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $11 Million - $19.8 Million	110,796 Added 80.0%	249,296 $31.5 Million
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $17.5 Million - $21.2 Million	138,500 New	138,500 $21.2 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kerrisdale Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kerrisdale Advisers, LLC with notifications on news.

Account

Kerrisdale Advisers, LLC Charles River Laboratories International, Inc. Transaction History